Recently, a new subset of ILCs, regulatory ILCs, has been reported, which releases IL-10 following TGF-β signaling to play a tumor-promoting role (Wang et al., 2017; Bald et al., 2019; Wang et al., 2020b). This evidence concerns the gene IL10 and neoplasm.